Strategic advantages of insulin-like growth factor-I expression for cardioprotection.

Chao W, Matsui T, Novikov MS, Tao J, Li L, Liu H, Ahn Y, Rosenzweig A. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med. 2003 Apr; 5(4):277-86.

View in: PubMed

subject areas

Adenoviridae
Animals
Autocrine Communication
Cells, Cultured
Genetic Vectors
Humans
Insulin-Like Growth Factor I
Myocardial Ischemia
Myocardium
Myocytes, Cardiac
Paracrine Communication
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-akt
Rats
Receptor, IGF Type 1
Signal Transduction

authors with profiles

Takashi Matsui, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support